![Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis | Scientific Reports Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep41271/MediaObjects/41598_2017_Article_BFsrep41271_Fig1_HTML.jpg)
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis | Scientific Reports
![Hormonal regulation of Tdo2 expression. (A) Real-time PCR analysis of... | Download Scientific Diagram Hormonal regulation of Tdo2 expression. (A) Real-time PCR analysis of... | Download Scientific Diagram](https://www.researchgate.net/publication/258282389/figure/fig6/AS:668628923998237@1536424966952/Hormonal-regulation-of-Tdo2-expression-A-Real-time-PCR-analysis-of-Tdo2-expression-in.png)
Hormonal regulation of Tdo2 expression. (A) Real-time PCR analysis of... | Download Scientific Diagram
![Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay - ScienceDirect Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0968089621001681-ga1.jpg)
Parallel discovery of selective and dual inhibitors of tryptophan dioxygenases IDO1 and TDO2 with a newly-modified enzymatic assay - ScienceDirect
Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2) | ACS Medicinal Chemistry Letters
![Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities - ScienceDirect Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165614717302249-gr1.jpg)
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities - ScienceDirect
![TDO2 is upregulated in HCC tissues and is correlated with progression... | Download Scientific Diagram TDO2 is upregulated in HCC tissues and is correlated with progression... | Download Scientific Diagram](https://www.researchgate.net/publication/342125000/figure/fig4/AS:903461549916171@1592413427965/TDO2-is-upregulated-in-HCC-tissues-and-is-correlated-with-progression-and-poor-prognosis.png)